Company Overview and News

 
SBI looks to drag Videocon oil subsidiary to NCLT

6h freepressjournal.in
Mumbai : State Bank of India (SBI) may refer overseas oil and gas subsidiary of Videocon Group for insolvency proceedings at National Company Law Tribunal (NCLT), and is seeking a legal view before filing the petition, according to sources close to the development.
SBAZ

 
Mohapatra is MD, CEO of Central Bank

6h freepressjournal.in
Mumbai: Pallav Mohapatra has been appointed as the managing director & chief executive officer of Central Bank of India with effect from September 21. Prior to this appointment Mohapatra was the deputy managing director of State Bank of India. Mohapatra joined SBI as a probationary officer in 1983 and has handled many important assignments and portfolios for over two-and-a-half decades in the bank.
SBAZ

 
Essar Steel auction: Attention turns to ArcelorMittal#39;s stake sale in Uttam Galva

20h moneycontrol
The ongoing Supreme Court hearing on applications from ArcelorMittal and Numetal may have started over the eligibility of the Lakshmi Mittal-company to bid for Essar Steel.
513216 UTTAMSTL SBAZ

 
An evening walk down Dalal Street | A volatile end to the week, Sensex falls 279 pts; DHFL tanks 45%

22h moneycontrol
A largely volatile day has come to a close, with indices ending the day on a negative note. However, they are off the day’s low points. The Nifty has managed to give up 11,200 in today’s trade. The Sensex has closed over 200 points lower.
BHRYY 532617 511288 535789 534816 INFRATEL LHFLY 500253 GRAVITA SBAZ GRUH YESBANK KMBKY 511072 533282 IDKQY JETAIRWAYS GRHFY 532648 YYBKY IBULHSGFIN DHFL LICHSGFIN KOTAKBANK 500247

 
Small lenders to submit report on stressed power assets by October 10

2018-09-21 moneycontrol
Small lenders will submit their resolution plans on stressed power assets to a group of bankers and assess the situation on October 10, Financial Express reported quoting people aware of the development.
PWQFY 500116 AXB IBN IDBI 532810 532215 AXBKY PFC AXBA ICICIBANK PNJZY 532461 AXISBANK 532174 PNB SBAZ

 
SBI rises 2% as bank concludes $ 650 million green bond issue

2018-09-21 moneycontrol
Shares of State Bank of India (SBI) gained 2.6 percent intraday Friday after bank concluded the issuance of USD 650 Mio Green Senior Unsecured Fixed Rate Notes programme.
SBAZ

 
BNP Paribas Cardif to sell stake in SBI Life Insurance

2018-09-21 livemint
Mumbai: French insurer BNP Paribas Cardif has appointed three investment banks to scout for buyers for a portion of its stake in SBI Life Insurance Co. Ltd that is worth at least $500 million, said two people aware of the development. BNP Paribas Cardif formed the life insurance joint venture with state-run lender State Bank of India (SBI) in 2001. SBI currently owns 62.1% in the company while BNP Paribas Cardif holds 22%.
BNPZY BNPQY BNPQF SBAZ

 
SBI is not right candidate to acquire more banks: Chief

2018-09-21 freepressjournal.in
New Delhi : The country’s largest lender State Bank of India on Thursday said it is not in a position to acquire more banks at the moment as it needs 2-3 years to see gains from the consolidation effected last year.
SBAZ

 
IL&FS plans fire sale of financial services unit

2018-09-21 livemint
Mumbai/New Delhi: Infrastructure Leasing and Financial Services Ltd (IL&FS) is planning to sell a majority stake in its financial services unit and additional assets worth ₹ 4,500 crore to pay down debts as the company rushes to meet its obligations and avoid bankruptcy. IL&FS has also asked the government to clear dues worth as much as ₹ 16,000 crore for work completed by the company, three executives familiar with the development said, requesting anonymity.
HDFC 500010 HDFC SBAZ

 
5 parties bidding for 74% Malaysian Maxis owned Indian Aircel assets

2018-09-20 thestar.com.my
Aircel, which is 74% owned by Maxis Communications Bhd, reportedly owes about 50,000 crores to its creditors. Aircel is among the casualties of the intense competition in the Indian telecom market.
SRLRY 532454 RCOM 532374 PNJZY 532461 PNB STRTECH 532712 BHRQY BHARTIARTL SBAZ

 
Airtel, Sterlite Tech, two investment firms in race to buy Aircel assets

2018-09-20 moneycontrol
The assets of the beleaguered telecom company Aircel are up for sale and Bharti Airtel, Sterlite Technologies, among others and two investment firms are reportedly keen to separately buy them. Despite the number of interested buyers, the lenders to Aircel may still have to take a large haircut, according to Livemint.
SRLRY 532454 532374 PNJZY 532461 PNB STRTECH BHRQY BHARTIARTL SBAZ

 
Vietnam Is One Of The Most Resilient EMs

2018-09-20 seekingalpha
Equity multiple compression has come about following EM sell-off since April, but earnings have continued to grow at historic rates. The return of foreign capital could be key upside catalyst.
SBAZ

 
SBI hopes to resolve 7-8 stressed power assets until November 11: Chairman Rajnish Kumar

2018-09-20 moneycontrol
State Bank of India hopes to resolve 7-8 stressed power assets with an exposure of around Rs 17,000 crore during the breather given by the Supreme Court till November 11, SBI Chairman Rajnish Kumar said Thursday.
INDIANB UBNC PNJZY 532461 532483 532480 ALBK 532814 PNB CANBK SBAZ CNRYY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 856121108